Tuesday, 02 January 2024 12:17 GMT

Frontieras North America Announces Confidential Submission Of Draft Registration Statement For Proposed Initial Public Offering


(MENAFN- GlobeNewsWire - Nasdaq) HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- via IBN – Frontieras North America today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed initial public offering is subject to the completion of the SEC review process, as well as market and other conditions.

This press release is issued pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the "Securities Act"). This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.

About Frontieras North America

Frontieras North America is an energy and environmental technology company commercializing FASFormTM, a patented Solid Carbon Fractionation process that transforms coal and other hydrocarbons into clean-burning fuels, hydrogen, industrial carbon, and agricultural products. The company is focused on delivering abundant, affordable, and available energy through profitable, market-driven innovation.

Contact: ...

IBN.Ai
Austin, Texas

512.354.7000 Office
...



MENAFN03092026004107003653ID1111617385



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story